Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6113707 | Critical Reviews in Oncology/Hematology | 2013 | 17 Pages |
Abstract
Various cancer treatment approaches have shown promising results when tested preclinically. The results of clinical trials, however, are often disappointing. While searching for the reasons responsible for their failures, the relevance of experimental and preclinical models has to be taken into account. Possible factors that should be considered, including cell modifications during in vitro cultivation, lack of both the relevant interactions and the structural context in vitro have been summarized in the present review.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Beata ÄunderlÃková,